BridgeMD
New treatment option for Pancreatic Fistula
Official title Reinforced Pancreaticojejunostomy With or Without glubran2
ClinicalTrials.gov ID: NCT06756074
What this study is testing
What is Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2)?
Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) is an investigational medicine, being studied as a potential treatment for pancreatic fistula.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- All the patients undergoing pancreaticoduodenectomy for cancer
- Patients able to give their informed consent
You likely can't join if
- Unfit patients for surgery due to severe medical illness.
- Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
- Presence of distant metastasis .
- Patients refused to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Minya, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minya, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.